Providing a rapid, PCR COVID-19 testing solution to the UK film & TV industry NEWCASTLE UPON TYNE, UK, 16 August 2021. QuantuMDx has announced it is partnering with Cignpost Diagnostics, (‘Cignpost’), a leading provider of COVID-19 workplace testing to the film and TV industry. Cignpost has installed QuantuMDx’ portable Q-POC™ system onto a filming location within the UK, providing rapid, onsite PCR testing for cast and crew members, to ensure a safe working environment thus allowing filming to progress without interruption…
Positioned to deliver…
Seasoned management team and Board with extensive experience in R&D, manufacturing and commercialisation within the life sciences sector.
In-house and external regulatory specialists supporting CE mark, WHO PQ and FDA 510(k) market clearance.
IS0 13485: 2016
Comprehensive proprietary IP portfolio
Transformational point-of-care molecular diagnostic platform
Long-standing, validating relationships with key advisers and partners
Strong product pipeline: respiratory panel, HPV, STIs
QuantuMDx is an ambitious UK-based life science tools and diagnostics company. We have developed a highly innovative, portable molecular diagnostic platform, Q-POC™ which offers rapid, sample to answer, multiplexed testing within 30 minutes, at the point of care.
Find out more
Our announcements, achievements and latest news